The Peptide Report
The 3 PM crash isn't a coffee problem — it's a cellular energy problem. Here's why high-performers are quietly switching from their third espresso to a doctor-formulated NAD+ nasal spray.
The 5 PM crash isn't a willpower problem—it's a cellular one. Inside the quiet shift among Wall Street's highest performers toward intranasal NAD+ and the biology that explains why it's working.
Inside the quiet shift among finance, law, and tech leaders away from caffeine and toward intranasal NAD+. A look at the cellular science driving the new executive performance playbook.
The afternoon crash isn't a willpower problem—it's a mitochondrial one. Here's why high-performers are quietly trading their 3 PM espresso for a faster, cleaner cellular reset.
